Bluefin Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | -$978K | – | 164 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 46 |
|
|
2022
Q2 | – | Sell |
-138,485
| Closed | -$12.4M | – | 487 |
|
|
2022
Q1 | $12.4M | Sell |
138,485
-38,257
| -22% | -$3.44M | 1.14% | 11 |
|
|
2021
Q4 | $19.8M | Sell |
176,742
-58,024
| -25% | -$6.5M | 1.38% | 16 |
|
|
2021
Q3 | $29.5M | Buy |
+234,766
| New | +$29.5M | 2.93% | 6 |
|
|
2020
Q2 | – | Sell |
-113,853
| Closed | -$8.82M | – | 286 |
|
|
2020
Q1 | $8.82M | Buy |
+113,853
| New | +$8.82M | 1.14% | 17 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 464 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 346 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 308 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 307 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 344 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 368 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 347 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 405 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 599 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 461 |
|